PTEN and neoplasm: Based on these results, we can make a hypothesis that activation of Wnt signaling by antagonist methylation could confer tumors the characters of stem cell, which consequently causes tumors resistant to EGFR TKIs therapy by generating acquired resistance, such as MET amplification or changes of PTEN tumor suppressor activity and so on.